First reported 21 hours ago -
Updated 14 hours ago -
Four legislative actions could ease the burden of high-cost prescription drugs—such as a $1,000-per-pill hepatitis C drug—on Medicare
, the public, and commercial payers, says U.S. Rep. Henry Waxman.Calling Sovaldi, a high-priced drug for hepatitis C, ...
[Published Health Leaders - 18 hours ago]